Table 5 Secondary efficacy parameters in the intent-to-treat population
Arm A | Arm B | Arm C | Arm D | |
|---|---|---|---|---|
Months | Months | Months | Months | |
Duration of response and stabilisation | 5.9 (0.8–12.7) | 3.9 (1.0–13.0) | 5.3 (1.3–8.9) | 3.4 (1.3–6.9) |
Time to progression | 2.7 (1.0–12.8) | 3.5 (0.0–13.2) | 3.8 (0.0–8.9) | 2.8 (0.0–7.0) |
Time to treatment failure | 2.7 (1.0–12.8) | 2.3 (0.6–8.3) | 3.2 (0.4–7.1) | 1.7 (0.5–7.1) |
Survival | 9.4 (1.0–15.3) | 7.1 (0.6–13.5) | 8.6 (0.7–16.7) | 6.4 (1.1–15.1) |
